Rejuvenation Technologies is a biotechnology company focused on reversing cellular aging by lengthening telomeres in human cells. Based in Mountain View, California, they develop targeted delivery using lipid nanoparticles and modified mRNA to activate telomerase, aiming to treat age-related diseases. Their research includes pulmonary fibrosis, liver disease, and bone marrow failure, with early clinical trial plans in Australia.
No recent news for this company.
No recent deals for this company.